• SENSEX 74,459.53
    308.49 (+0.42%)
  • BANKNIFTY 54,909.65
    642.25 (+1.18%)
  • Jio Platforms
    1,438.95 1,490.00(%)
  • NSE
    1,775.20 1,640.25(%)
  • Dalmia BharatLtd
    1,320.00 1,403.50(%)
  • Anand Rathi Wea.
    2,246.45 1,354.00(%)
  • Ather Energy
    1,782.05 1,741.90(%)
  • Reliance Industries
    1,152.50 1,152.30(%)
  • Laurus Labs
    2,392.00 2,245.00(%)
  • Sagility
    41.79 35.82(%)
  • UltraTech Cem.
    11,005.00 10,329.00(%)
  • Tonbo Imaging
    1,330.00 1,343.80(%)
  • Indian Hotels Co
    824.00 816.00(%)
  • Trent
    3,059.00 3,399.75(%)
  • HDFC Bank
    695.50 1,017.90(%)
  • ICICI AMC
    2,688.00 2,528.90(%)
  • Hexaware Tech.
    497.95 400.35(%)
  • Suzlon Energy
    33.21 36.30(%)
  • Godrej Consumer
    777.65 810.35(%)
  • Diamond Power
    350.00 406.80(%)
  • Equitas Sma. Fin
    47.26 51.30(%)
  • APL Apollo Tubes
    2,161.00 1,691.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bharat Parenterals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3882.0
  • ISIN : INE365Y01019
1,912.60 0 (-0.02%)
  • As on 30 Oct 2026 (EOD)
  • Today’s Low

    1,869.10
  • Today’s High

    1,932.00
  • Open

    1,912.90
  • Perv Close

    1,912.90
  • 52W Low

    1,125.70
  • 52W High

    2,277.60

Key Indicators

  • P/E(TTM)

    136.05

  • Mar.Cap (₹Cr.)

    1,318.16

  • Div & Yield %

    0.05

  • Book Value(₹)

    583.79

  • Debt-Equity Ratio

    -0.02

  • AGM Date

    29-Oct-2026

  • EPS

    14.04

  • P/E Ratio

    136.05

Financials Ratios

  • Debt-Equity Ratio

    0.55

  • Mar.Cap (₹Cr.)

    1,318.16

  • RONW (%)

    5.53

  • ROCE (%)

    7.69

Score Board

  • Equity (₹ in Cr.)

    6.89

  • BV (₹)

    583.80

  • Sales( ₹ in Cr.)

    234.01

  • NP (in Cr.)

    15.80

  • NP Var(%)

    -42.0

  • Div%

    10.0

  • CPS (₹)

    35.10

  • EPS (₹)

    22.90

  • Traded Value (₹ in Lakhs)

    1,316.47

  • 52 Week High

    2,277.60

  • 52 Week Low

    1,125.70

  • Price BSE

    1910.0

  • Price NSE

    1,913.00

  • Market Capital( in Cr.)

    1,316.47

  • P/C Ratio

    54.50

  • P/E Ratio

    83.30

  • Price Vs.BV

    22.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 234.01 304.13 257.98 252.73 240.92 203.67
Excise Duty 0.00 0.00 0.00 34.75 28.91 0.00
Net Sales 234.01 304.13 257.98 217.98 212.01 203.67
Other Income 12.55 14.55 8.04 18.84 7.78 8.67
Stock Adjustments -2.05 -10.14 15.19 9.75 -1.68 -1.88
Total Income 244.51 308.54 281.21 246.57 218.11 210.46
EXPENDITURE :            
Raw Materials 149.90 179.46 173.71 147.23 134.39 132.16
Power and Fuel Cost 4.42 4.63 4.24 3.73 2.98 3.10
Employee Cost 25.13 21.38 19.62 16.93 15.26 14.39
Other Manufacturing Expenses 14.13 13.07 11.29 10.06 7.42 6.39
Selling and Administration Expenses 12.94 34.59 26.79 23.54 13.82 13.77
Miscellaneous Expenses 4.34 7.26 4.58 4.50 7.91 6.85
Employee Benefit Expenses 25.13 21.38 19.62 16.93 15.26 14.39
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 210.87 260.39 240.22 205.99 181.78 176.66
Operating Profit 33.65 48.16 41.00 40.59 36.34 33.81
Interest 3.44 4.79 3.80 2.57 1.31 0.76
Gross Profit 30.21 43.37 37.20 38.02 35.03 33.05
Depreciation 8.36 7.05 6.40 5.85 6.66 6.03
Profit Before Tax 21.85 36.32 30.80 32.17 28.37 27.02
Current Tax 6.96 10.58 8.66 8.40 8.01 7.09
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.13 -0.72 -0.45 -0.57 -0.94 -0.28
Reported Net Profit 16.02 26.45 22.59 24.34 21.30 20.21
Extraordinary Items 0.22 -0.71 -0.03 4.55 -0.53 0.16
Adjusted Net Profit 15.80 27.16 22.62 19.79 21.83 20.05
Adjustment below Net Profit 0.19 0.06 -0.20 0.04 -0.23 0.16
P & L Balance brought forward 231.09 205.16 183.19 158.81 137.74 117.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.69 0.58 0.43 0.00 0.00 0.00
P & L Balance carried down 246.60 231.09 205.16 183.19 158.81 137.74
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 7.50 0.00 0.00
Dividend Per Share(Rs) 1.00 1.00 1.00 0.75 0.00 0.00
Earnings Per Share-Unit Curr 23.24 38.38 38.82 42.14 36.89 35.27
Earnings Per Share(Adj)-Unit Curr 23.24 38.38 38.82 42.14 36.89 35.27
Book Value 583.78 561.27 367.05 330.86 287.72 251.22
Book Value(Adj)-Unit Curr 583.78 561.27 367.05 330.86 287.72 251.22

Shareholding Pattern

  • Promoter Group

    67.20%

  • Public Share Holding

    32.80%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,750,053 39.90 2,750,053 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,881,484 27.30 1,881,484 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,631,537 67.20 4,631,537 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,244 0.11 7,244 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 5,045 0.07 5,045 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 83,534 1.21 83,534 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 96,323 1.40 95,823 6
2] Non Institution
Bodies Corporate 543,017 7.88 197,487 58
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 255,544 3.71 249,044 61
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 47,117 0.68 43,917 98
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 375,984 5.46 375,984 6
Individuals holding nominal share capital up to Rs. 1 lakh 941,690 13.66 770,265 3,470
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 751 0.01 751 1
Others 0 0.00 0 0
Sub Total 2,164,103 31.40 1,637,448 3,694
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,891,963 100.00 6,364,808 3,709

Company Background

Bharat Parenterals LtdPharmaceuticals - Indian - Formulations

  • Bharat Parenterals Ltd
  • BSE Code : 3882.0
  • ISIN : INE365Y01019
  • Incorporation Year

    1992

  • Registered Office

    Survey No 144 & 146 Haripura
    Jarod Samlaya Road Tal Savli, Vadodara,
    Gujarat-391520

  • Telephone

    91-2667-251679

  • FAX

    91-2667-251670

  • Chairman

    Bharat Kumar R Desai

  • Managing Director

    Bharat Kumar R Desai

  • Company Secretary

    Sharmin Nareshkumar Soni

  • Auditor

    Shah Mehta & Bakshi

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Adroit Corporate Serv. Pvt Ltd
    205/206 Sterling Cen,
    R C Dutt Road ,Alkapuri
    Mumbai - Vadodara - 390007

Bharat Parenterals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bharat Parenter. 1,910.15 246.57 234.01 136.05 5.74
Abbott India 26,107.90 7,217.19 6,929.05 34.36 43.78
Astrazeneca Phar 6,298.05 2,304.07 2,275.58 92.82 27.86
Glaxosmi. Pharma 2,515.65 3,932.76 3,790.20 40.19 58.17
Novartis India 1,813.30 393.10 354.33 45.79 15.94
Cipla 1,357.00 20,102.60 18,979.95 41.36 13.88
Bliss GVS Pharma 682.50 773.53 729.81 63.43 12.51
Amrutanjan Healt 493.40 520.13 502.55 26.43 24.16
Fermenta Biotec. 439.75 474.15 450.25 20.53 18.77
Guj. Themis Bio. 374.85 168.25 165.82 100.23 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77